is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
UCLA transplant programs have maintained a remarkably cohesive surgical, medical and support staff, which forms an experienced and committed team to face the challenges of organ transplantation. Physicians in many subspecialties act as consultants to the transplant programs, and their breadth of experience enhances the clinical success of all of the transplant programs at UCLA.
Please join us as UCLA Health leaders in Heart and Lung Transplantation discuss UCLA Health’s excellence in Heart, Lung, and Heart-Lung Transplantation. Moderated by Dr. Neveen El-Farra, Dr. Abbas Ardehali, Chair in Cardiothoracic Transplantation and Director of the UCLA Heart, Lung, and Heart-Lung Transplant Programs and Dr. Ali Nsair, Medical Director of UCLA Heart Transplantation and Mechanical Circulatory Support Device Services will present on UCLA Health’s transplantation clinical differentiators, approach and successes in complex organ transplantation. Participate in a Q&A session where you will have the opportunity to ask the experts questions on organ transplantation. Don’t miss out on this opportunity!
Dr. Abbas Ardehali is a Professor of Surgery and Medicine in the Division of Cardiothoracic Surgery and Director of the Heart, Lung and Heart-Lung Transplant Programs at The David Geffen School of Medicine at UCLA. In addition, Dr. Ardehali holds the William E. Conner Chair in Cardiothoracic Transplantation.
Dr. Ardehali has received many honors and awards including the American Heart Association, Established Investigator Award, and the Second Alfred Blalock Research Scholarship Award from the American Association for Thoracic surgery. He has also been recognized for his contribution to resident and student teaching, earning the Golden Apple Teaching Award at UCLA.
Dr. Ardehali is the author of numerous book chapters and more than 200 peer reviewed manuscripts and abstracts. He is on the editorial board for the Journal of Surgical Research and he is a reviewer for many journals including Circulation, and the Journal of Heart and Lung Transplantation. He has been the Chair of the Steering Committee for several multi-center international studies in the field of heart & lung transplantation. His research interests are ex-vivo organ perfusion in heart and lung transplantation. Dr.Ardehali was involved developing technology that allows for transporting a breathing human heart or lung for an extended period of time, and was the first surgeon in the United States to perform a 'breathing lung' transplant.
Dr. Nsair is the Director of the Heart Transplantation and Mechanical Circulatory Support Program at UCLA Health. He received his medical degree from the University of Alberta, where he also completed his Internal Medicine residency and Cardiology fellowship. He received advanced training in Advanced Heart Failure and Interventional Cardiology at UCLA Medical Center and a post-doctoral fellowship in Regenerative Therapies. As well, Dr. Nsair is an Interventional Cardiologist with focus on the high risk interventions in patients with advanced cardiac disease and structural interventions in patients with valvular disease.
His research interests include cardiovascular regenerative and rejuvenation therapies, as well as advanced studies of mechanical circulatory support devices in cardiogenic shock and novel heart failure medical therapies. Furthermore, his research interest involves mechanical circulatory support in patients with advanced heart failure and cardiogenic shock. He is involved in multiple national and international clinical and translational trials and is the PI for a basic and translational research lab. Understanding the native endogenous cardiac progenitor during the fetal stage will offer a model to recapitulate a multipotent progenitor cell from human induced pluripotent stem cells (hiPSC) to be used in cardiovascular regenerative therapies.
Dr. Nsair is also the Director of the Sports Cardiology Program at UCLA. The UCLA Sports Cardiology Program is the official program that provides care for the Los Angeles Lakers NBA team and the Los Angeles Dodgers MLB team. The UCLA Sports Cardiology Program offers professional level care and cardiac clearance for elite athletes and sports enthusiasts. His research interest in Sports Cardiology and Advanced Heart Failure includes novel wearable technology for remote telemonitoring of patients from home as well as athletes to biometric monitoring.
Dr. Neveen El-Farra is a Professor of Clinical Medicine and a Hospitalist in the Department of Medicine at the David Geffen School of Medicine (DGSOM) at UCLA. Dr. El-Farra currently serves as an Associate Program Director for the Internal Medicine Residency Program in the Department of Medicine at UCLA. She served as the Associate Dean for Curricular Affairs at the David Geffen School of Medicine at UCLA from December 2014 through July 2019. She has received numerous awards for her teaching, service and humanism. Among these awards and honors include the Award for Excellence in Education from DGSOM. She is a five-time recipient of the Golden Apple Award for Excellence in Teaching from medical students and residents. She was also selected as a faculty inductee for the Gold Humanism Honor Society (GHHS) in 2017, and currently serves as the GHHS Chapter Advisor. Most recently, she was selected as a recipient of the 2019-2020 Distinguished Teaching Senate Faculty Award at UCLA.
Dr. El-Farra served as a physician advisor to UCLA Health International Services from August 2018- June 2020. As a physician advisor, she participated in several key international collaborations and projects with UCLA Health. In July 2020, Dr. El-Farra was appointed as Medical Director for International Services for UCLA Health where she works closely with the team on strategic initiatives and patient care operations. She is committed to ensuring that international patients at UCLA Health receive high quality, empathetic, and culturally humble patient care. Dr. El-Farra takes great pride to be at UCLA Health and be part of an institution that upholds a vision to “heal humankind one patient at time by alleviating suffering and delivering acts of kindness”.